-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

Benzinga·11/13/2026 13:33:03
B of A Securities analyst Joshua Dennerlein downgrades National Health Investors (NYSE:NHI) from Buy to Underperform and lowers the price target from $86 to $67.